News
Healthcare giants AbbVie and Abbott Laboratories are both Dividend Kings. They should maintain their dividend growth habits ...
Abbott and Beta Bionics are collaborating to integrate Abbott’s upcoming dual glucose-ketone sensor with Beta’s iLet Bionic ...
Abbott Laboratories (NYSE:ABT) is one of the high profit margin stocks to buy now. On June 19, Beta Bionics Inc. (NASDAQ:BBNX ...
Abbott's mixed reality technology helps distract blood donors and reduce their anxiety levels. This can help encourage young ...
4d
Zacks Investment Research on MSNAbbott Sees Upside on Diagnostics Growth, FreeStyle Libre ExpansionAbbott’s ABT diversified business portfolio appears to be well-positioned to drive continued momentum in 2025. The stock carries a Zacks Rank #2 (Buy) currently. Factors Driving ABT Shares Within ...
The American Diabetes Association, now endorses automated insulin delivery (AID) systems as the leading approach for ...
The American Diabetes Association's McCormick Place event was also a bit of a coming out party for North Chicago-based Abbott ...
13d
Zacks Investment Research on MSNBBNX Stock May Gain From Abbott Deal to Advance iLet IntegrationBeta Bionics, Inc. BBNX recently entered into a strategic agreement with Abbott Laboratories ABT to integrate its iLet Bionic ...
Tandem Diabetes' t:slim X2 pump with Control-IQ+ tech gains U.S. early access using FreeStyle Libre 3 Plus sensor.
Tandem Diabetes Care has announced its Tandem t:slim X2 insulin pump is now compatible with Abbott’s FreeStyle Libre 3 Plus ...
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results